{"id":"https://openalex.org/W2332819500","doi":"https://doi.org/10.1097/01.qai.0000397327.26622.5c","title":"141 Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1","display_name":"141 Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2332819500","doi":"https://doi.org/10.1097/01.qai.0000397327.26622.5c","mag":"2332819500"},"language":"en","primary_location":{"id":"doi:10.1097/01.qai.0000397327.26622.5c","doi":"https://doi.org/10.1097/01.qai.0000397327.26622.5c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000397327.26622.5c","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050990123","display_name":"Iliyana Mikell","orcid":"https://orcid.org/0000-0002-9068-5538","observed_orcids":["https://orcid.org/0000-0002-9068-5538"]},"institutions":[{"id":"https://openalex.org/I1294824412","display_name":"Center for Infectious Disease Research","ror":"https://ror.org/04jkbnw46","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1294824412"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Iliyana Mikell","raw_affiliation_strings":["Department of Global Health, University of Washington, Seattle, Washington","Seattle BioMed, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Global Health, University of Washington, Seattle, Washington","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Seattle BioMed, Seattle, Washington","institution_ids":["https://openalex.org/I1294824412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087526268","display_name":"D. Noah Sather","orcid":"https://orcid.org/0000-0002-9128-172X","observed_orcids":["https://orcid.org/0000-0002-9128-172X"]},"institutions":[{"id":"https://openalex.org/I1294824412","display_name":"Center for Infectious Disease Research","ror":"https://ror.org/04jkbnw46","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1294824412"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Noah Sather","raw_affiliation_strings":["Seattle BioMed, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle BioMed, Seattle, Washington","institution_ids":["https://openalex.org/I1294824412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067647063","display_name":"Spyros A. Kalams","orcid":"https://orcid.org/0000-0003-0098-7995","observed_orcids":["https://orcid.org/0000-0003-0098-7995"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spyros Kalams","raw_affiliation_strings":["Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN","Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN; and","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042817775","display_name":"Marcus A. Altfeld","orcid":"https://orcid.org/0000-0001-5972-2997","observed_orcids":["https://orcid.org/0000-0001-5972-2997"]},"institutions":[{"id":"https://openalex.org/I2802422659","display_name":"Ragon Institute of MGH, MIT and Harvard","ror":"https://ror.org/053r20n13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I2802422659","https://openalex.org/I4210087915","https://openalex.org/I48633490","https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcus Altfeld","raw_affiliation_strings":["Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA","institution_ids":["https://openalex.org/I2802422659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059371880","display_name":"Galit Alter","orcid":"https://orcid.org/0000-0002-7680-9215","observed_orcids":["https://orcid.org/0000-0002-7680-9215","https://orcid.org/0000-0002-9221-6735","https://orcid.org/0000-0003-1570-9445"]},"institutions":[{"id":"https://openalex.org/I2802422659","display_name":"Ragon Institute of MGH, MIT and Harvard","ror":"https://ror.org/053r20n13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I2802422659","https://openalex.org/I4210087915","https://openalex.org/I48633490","https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Galit Alter","raw_affiliation_strings":["Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA","institution_ids":["https://openalex.org/I2802422659"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002836913","display_name":"Leonidas Stamatatos","orcid":"https://orcid.org/0000-0002-1106-7097","observed_orcids":["https://orcid.org/0000-0002-1106-7097"]},"institutions":[{"id":"https://openalex.org/I1294824412","display_name":"Center for Infectious Disease Research","ror":"https://ror.org/04jkbnw46","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1294824412"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Leonidas Stamatatos","raw_affiliation_strings":["Department of Global Health, University of Washington, Seattle, Washington","Seattle BioMed, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Global Health, University of Washington, Seattle, Washington","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Seattle BioMed, Seattle, Washington","institution_ids":["https://openalex.org/I1294824412"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5002836913"],"corresponding_institution_ids":["https://openalex.org/I1294824412","https://openalex.org/I201448701"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"56","issue":"Supplement 2","first_page":"57","last_page":"57"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cross-neutralizing-antibodies","display_name":"cross-neutralizing antibodies","score":0.9290000200271606},{"id":"https://openalex.org/keywords/hiv-1-envelope-glycoprotein","display_name":"HIV-1 envelope glycoprotein","score":0.8500000238418579},{"id":"https://openalex.org/keywords/gp120","display_name":"gp120","score":0.8080000281333923},{"id":"https://openalex.org/keywords/cd4-binding-site","display_name":"CD4 binding site","score":0.9610000252723694},{"id":"https://openalex.org/keywords/antibody-epitope-specificity","display_name":"antibody epitope specificity","score":0.6729999780654907},{"id":"https://openalex.org/keywords/antibody-persistence","display_name":"antibody persistence","score":0.3659999966621399}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.9325419664382935},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7846938967704773},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7440017461776733},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.7352544069290161},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.6751940846443176},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.46217647194862366},{"id":"https://openalex.org/C14086860","wikidata":"https://www.wikidata.org/wiki/Q337120","display_name":"Neutralization","level":3,"score":0.45854878425598145},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.43204233050346375},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4152419865131378},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.345727801322937},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.13476890325546265}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.qai.0000397327.26622.5c","doi":"https://doi.org/10.1097/01.qai.0000397327.26622.5c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000397327.26622.5c","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1974273518","https://openalex.org/W2084310667","https://openalex.org/W2010091236","https://openalex.org/W2086641359","https://openalex.org/W2612519787","https://openalex.org/W2298966435","https://openalex.org/W2170368559","https://openalex.org/W2735187794","https://openalex.org/W1963519403","https://openalex.org/W2073538899"],"abstract_inverted_index":{"Recent":[0],"cross-sectional":[1],"analyses":[2],"of":[3,19,26,29,42,49,58,105,154,159,184],"HIV-1+":[4,22],"plasmas":[5],"indicated":[6],"that":[7,67,116,133,141],"broadly":[8],"cross-reactive":[9],"neutralizing":[10,102],"antibody":[11,50,70,90,103,128,174],"responses":[12,32,44,71,91,104,129,175],"are":[13,117,134,142],"developed":[14],"by":[15],"10%":[16],"-":[17],"30%":[18],"anti-retroviral":[20],"na\u00efve":[21],"subjects.":[23],"The":[24,156],"timing":[25],"the":[27,40,47,59,111,120,125,137,165],"development":[28],"such":[30],"anti-viral":[31],"is":[33,36,170],"unknown.":[34],"It":[35],"also":[37],"unknown":[38],"whether":[39],"emergence":[41],"these":[43,160],"coincides":[45],"with":[46],"appearance":[48],"specificities":[51,163],"to":[52,95,164],"a":[53],"single":[54],"or":[55,139],"multiple":[56],"regions":[57],"viral":[60],"envelope":[61],"glycoprotein":[62],"(Env).":[63],"Here":[64],"we":[65],"report":[66],"anti-HIV-1":[68],"cross-neutralizing":[69,89,127,168,173],"first":[72],"become":[73],"evident,":[74],"on":[75,110,145,150],"average,":[76],"at":[77],"2.5":[78],"years,":[79],"and":[80,186],"as":[81,83],"early":[82],"1":[84],"year,":[85],"following":[86],"infection.":[87,99],"Broad":[88],"do":[92,178],"not":[93,143,179],"appear":[94],"develop":[96],"later":[97],"in":[98],"Although":[100],"plasma":[101],"narrow":[106],"breadth,":[107],"target":[108,131],"epitopes":[109,132,140],"monomeric":[112,146],"gp120":[113,147],"Env":[114],"subunit":[115],"located":[118,135],"outside":[119],"conserved":[121],"CD4-binding":[122],"site":[123],"(CD4-BS),":[124],"earliest":[126],"primarily":[130],"within":[136],"CD4-BS":[138],"present":[144,149],"but":[148],"virion-associated":[151],"trimeric":[152],"form":[153],"Env.":[155],"relative":[157],"contribution":[158],"two":[161],"epitope":[162],"plasma's":[166],"overall":[167],"activities":[169],"patient-depended.":[171],"Once":[172],"emerge,":[176],"they":[177],"wane":[180],"for":[181],"extended":[182],"periods":[183],"time":[185],"their":[187],"epitope-specificities":[188],"remain":[189],"unchanged.":[190]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}